See also this year's filing and all EDGAR filings for this company.
PDF Report 0001173313_2025_ABVC_Biopharma_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001173313, ABVC Biopharma INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 2,179,815 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 511,088 |
| 3 | remainder_Assets | 4,849,004 |
| 4 | LiabilitiesCurrent | 6,557,461 |
| 5 | LiabilitiesNoncurrent | 236,807 |
| 6 | remainder_Liabilities | 21,680 |
| 7 | CostOfGoodsAndServicesSold | 15,641 |
| 8 | SellingGeneralAndAdministrativeExpense | -3,455,436 |
| 9 | ResearchAndDevelopmentExpense | 167,121 |
| 10 | remainder_Expenses | 2,626,323 |
| 11 | remainder_Revenues | 359,654 |
| 12 | remainder_NetIncome | -1,294,099 |
| 13 | remainder_ComprehensiveNetIncome | 315,110 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 7,539,907 |
| 1 | Liabilities | 6,815,948 |
| 2 | Expenses | -646,351 |
| 3 | Revenues | 359,654 |
| 4 | StockholdersEquity | 723,959 |
| 5 | NetIncome | -288,094 |
| 6 | ComprehensiveNetIncome | -130,539 |
| 7 | BaseVar | 8,485,534 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.202 |
| 9 | EconomicCapitalRatio | 1.61 |
Edgar->Model Mapping
Feature Distribution
Change over Time
